General Information
Version
5.0
Revision date
2022-08-01
Product name
K 12
1.2.2. Uses advised against
on use For commercial application only
Emergency telephone
070 245 245
Icons in SDS
Company Information
company name
ASSYST bvba
e-mail address of the competent person responsible for the Safety Data Sheet
ao@assyst.org, vera.opsommer@assyst.org
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H411
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification according to directive (EC) No
Health hazards
Skin corrosion/irritation, Category 2 - H315: Causes skin irritation. Eye irritation, Category 2 - H319: Causes severe eye irritation. Skin sensitisation, Subcategory 1B - H317: May cause an allergic skin reaction. (Chronic) Aquatic long-term hazard, Category 2 - H411: Toxic to aquatic organisms with long-lasting effects.
2.2 Label elements
Labelling
Signal word
Warning. Hazardous ingredients to be declared on the label: Reaction mass of trientine, mono- and di-propoxylated
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes severe eye irritation. H411 Toxic to aquatic organisms with long-lasting effects.
Prevention
P261 Avoid inhalation of dust/fume/gas/mist/vapour/spray. P264 After handling this product, wash skin thoroughly. P273 Avoid discharge into the environment. P280 Wear protective gloves/eye protection/face protection. Action: P333 + P313 In case of skin irritation or rash: consult a doctor. P391 Clean up any leaks/spills.
2.3 Other hazards
This substance/mixture does not contain any components that can be considered persistent, bioaccumulative and toxic (PBT) or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain any components believed to have endocrine-disrupting properties according to REACH article 57(f) or Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at level 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain any components believed to have endocrine-disrupting properties according to REACH article 57(f) or Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at level 0.1% or higher.